Expression of epidermal growth factor receptor in cervical tissue and serum in patients with cervical neoplasia

Journal of Lower Genital Tract Disease

Volumn 8, Issue 4, 2004, Pages 292-297

  Kim, Seung Cheol ^a   Park, H M ^a   Lee, S N ^a   Han, W S ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Cervical neoplasia; EGFR; ELISA; Immunohistochemical staining

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; SERUM; UTERINE CERVIX; UTERINE CERVIX TUMOR;

EID: 4944256584     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200410000-00006     Document Type: Article

References (36)

1. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the Newborn animal. J Biol Chem 1962;237:1555-65.
2. Cohen S, Carpenter G. Human epidermal growth factor. Isolation and chemical and biological properties. Proc Nat Acad Sci U S A 1975;72:1317-21.
3. Carpenter G. The biochemistry and physiology of the receptor-kinase for epidermal growth factor. Mol Cell Endocrinol 1983;31:1-19.
4. Schlessinger J, Schreiber AB, Levi A, Lax I, Libermann T, Yarden Y. Regulation of cell proliferation by epidermal growth factor. CRC Crit Rev Biochem 1983;14:93-111.
5. Adamson ED, Rees AR. Epidermal growth factor receptors. Mol Cell Biochem 1981;34:129-52.
6. Cohen S. The epidermal growth factor (EGF). Cancer 1983;51:1787-91.
7. Carpenter G. Receptors for EGF and other polypeptide mitogens. Ann Rev Biochem 1987;56:881-914.
8. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinase. Ann Rev Biochem 1988;57:443-78.
9. Hendler FJ, Ozanne BW. Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest 1984;74:647-51.
10. Hunts J, Ueda M, Ozawa S, Abe O, Pastan I, Shimizu N. Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas. Jpn J Cancer 1985;76:663-6.
11. Sainsbury JRC, Farnon JR, Needham CK. Epidermal growth factor of early recurrence of and death from breast cancer. Lancet 1987;20:1398-402.
12. Nagan HYS, Cheung ANY, Liu SS, Cheng DKL, Ng TY, Wong LC. Abnormal expression of epidermal growth factor receptor and c-erb B2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis. Tumor Biol 2001;22:176-83.
13. Kersemaekers AM, van de Vijver MJ, Kenter GG, Fleuren GJ. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix. Gene Chromosomes Cancer 1999;26:346-54.
14. Kim JW, Kim YT, Kim DK, Song CH, Lee JW. Expression of epidermal growth factor receptor in carcinoma of the cervix. Gynecol Oncol 1996;60:283-7.
15. Choi JH, Oh JY, Ryu SK, Kim SJ, Lee NY, Kim YS, et al. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients. Cancer 1997;79:1879-83.
16. Partanen R, Hemminki K, Koskinen H, Luo JC, Carney WP, Brandt-Rauf PW. The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients. J Occup Med 1994;36:1324-8.
17. Hunter EJ, Cooper JA. Protein tyrosine kinase. Am Rev Biochem 1985;54:897-902.
18. Haigler HT, McKanna JA, Cohen S. Direct visualization on of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J Cell Biol 1979;81:382-95.
19. Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD. Expression of epidermal growth factor receptors on human cervical, ovarian, and vulvar carcinoma. Cancer Res 1986;46:285-92.
20. Cerny T, Barnes DM, Hasleton P, Barber PV, Healy K, Gullick W, et al. Expression of epidermal growth factor receptor (EGF-R) in human lung tumors. Br J Cancer 1986;54:265-9.
21. Veale D, Ashcroft T, Marsh C, Gibson GJ, Harris AL. Epidermal growth factor receptors in non-small cell lung cancer. Br J Cancer 1987;55:513-6.
22. Yoshida K, Tsuda T, Matsumura T, Tsujino T, Hattori T, Ito H, et al. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;57:285-90.
23. Han GT, Lee HG, Yoo WS. Expression of p53, proliferating cell nuclear antigen (PCNA), c-myc and epidermal growth factor receptor (EGFR) in uterine cervical cancer. Kor J Obstet Gynecol 1997;40:2680-90.
24. Yamasaki M, Mauro T, Akahori T, Mochizuki M. Immunohistochemical studies on epidermal growth factor receptor and myc oncogene product in squamous cell carcinoma of the uterine cervix. Acta Obstet Gynaec Jpn 1988;40:51-61.
25. Ruck A, Paulie S. The epidermal growth factor receptor is involved in autocrine growth of human bladder carcinoma cell lines. Anticancer Res 1997;17:1925-31.
26. Kim SC, Lee HP. Immunohistochemical study on EGFR expression in carcinoma of the uterine cervix. Kor J Obstet Gynecol 1990;33:1495-504.
27. Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito H, et al. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res 1988;48:137-41.
28. Lee EY, Cibull ML, Strodel WE, Haley JV. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. Arch Pathol Lab Med 1994;118:235-9.
29. c-erbB2. Oncology 1995;52:385-91.
30. Czerniak B, Herz F, Wersto RP, Alster P, Puszkin E, Schwarze E, et al. Quantitation of oncogene products by computer-assisted image analysis and flow cytometry. J Histochem Cytochem 1990;38:463-6.
31. Partanen R, Hemminki K, Koskinen H, Luo JC, Carney WP, Brandt-Rauf PW. The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients. J Occup Med 1994;36:1324-8.
32. Wu JT. C-erbB2 oncoprotein and its soluble ectodomain: a new potential tumor marker for prognosis early detection and monitoring patients undergoing Herceptin treatment. Clin Chim Acta 2002;322:11-9.
33. Oehler MK, Rehn M, Kristen P, Sutterlin M, Caffier H. Correlation of the EGF-receptor with cell kinetic and classical prognostic factors in breast cancer. Anticancer Res 1997;17:3137-40.
34. Dittadi R, Gion M. More about: prognostic importance of low c-erbB2 expression in breast tumors. J Natl Cancer Inst 2000;92:1443-4.
35. Osaki T, Mitsudomi T, Oyama T, Nakanishi R, Yasumoto K. Serum level and tissue expression of c-erbB2 protein in lung adenocarcinoma. Chest 1995;108:157-62.
36. Isola JJ, Holli K, Oksa H, Teramoto Y, Kallioniemi OP. Elevated erbB2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer. Cancer 1994;73:652-8.